These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 25722074)

  • 1. Differences in contraceptive use between family planning providers and the U.S. population: results of a nationwide survey.
    Stern LF; Simons HR; Kohn JE; Debevec EJ; Morfesis JM; Patel AA
    Contraception; 2015 Jun; 91(6):464-9. PubMed ID: 25722074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public and private providers' involvement in improving their patients' contraceptive use.
    Landry DJ; Wei J; Frost JJ
    Contraception; 2008 Jul; 78(1):42-51. PubMed ID: 18555817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
    Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
    J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-acting reversible contraception knowledge, attitudes and use among HIV-infected and -uninfected women and their providers.
    Teodoro N; Fu A; Ohly NT; Shalev N; Matseoane-Peterssen D; Westhoff CL
    Contraception; 2019 Oct; 100(4):269-274. PubMed ID: 31226320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urban-rural differences in attitudes and practices toward long-acting reversible contraceptives among family planning providers in Texas.
    Vaaler ML; Kalanges LK; Fonseca VP; Castrucci BC
    Womens Health Issues; 2012 Mar; 22(2):e157-62. PubMed ID: 22265180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraceptive knowledge, attitudes, and practice in Russia during the 1980s.
    Popov AA; Visser AP; Ketting E
    Stud Fam Plann; 1993; 24(4):227-35. PubMed ID: 8212092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher uptake of long-acting reversible and permanent methods of contraception by Australian women living in rural and remote areas.
    Lucke JC; Herbert DL
    Aust N Z J Public Health; 2014 Apr; 38(2):112-6. PubMed ID: 24690048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the provision of long-acting reversible contraception in California.
    Biggs MA; Harper CC; Malvin J; Brindis CD
    Obstet Gynecol; 2014 Mar; 123(3):593-602. PubMed ID: 24499746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young men's awareness and knowledge of intrauterine devices in the United States.
    Marshall CJ; Gomez AM
    Contraception; 2015 Nov; 92(5):494-500. PubMed ID: 26169342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The family planning attitudes and experiences of low-income women.
    Forrest JD; Frost JJ
    Fam Plann Perspect; 1996; 28(6):246-55, 277. PubMed ID: 8959414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's Contraceptive Preference-Use Mismatch.
    He K; Dalton VK; Zochowski MK; Hall KS
    J Womens Health (Larchmt); 2017 Jun; 26(6):692-701. PubMed ID: 27710196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Video Media in Clinic Waiting Areas Increases Interest in Most Effective Contraceptive Methods.
    Dineley B; Patel T; Black M; Koziarski R; Lamarche L; Costescu D
    J Obstet Gynaecol Can; 2018 Oct; 40(10):1302-1308. PubMed ID: 30005898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projections and opinions from 100 experts in long-acting reversible contraception.
    Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA
    Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors determining the choice of contraceptive methods at the Family Planning Clinic, University College Hospital, Ibadan, Nigeria.
    Konje JC; Oladini F; Otolorin EO; Ladipo OO
    Br J Fam Plann; 1998 Oct; 24(3):107-10. PubMed ID: 9855717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraceptive use and fertility in Guatemala.
    Monteith RS; Anderson JE; Pineda MA; Santiso R; Oberle M
    Stud Fam Plann; 1985; 16(5):279-88. PubMed ID: 4060213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey report: Pakistan.
    Zheng J
    Popul Today; 1991 Oct; 19(10):5. PubMed ID: 12284304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive use in Australia: evidence from the 1995 National Health Survey.
    Yusuf F; Siedlecky S
    Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):58-62. PubMed ID: 10099752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communication key for family planning.
    Hardee-cleaveland K
    Netw Res Triangle Park N C; 1992 Aug; 13(1):13. PubMed ID: 12317720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.